» Articles » PMID: 30837465

Assessing the Causal Association of Glycine with Risk of Cardio-metabolic Diseases

Abstract

Circulating levels of glycine have previously been associated with lower incidence of coronary heart disease (CHD) and type 2 diabetes (T2D) but it remains uncertain if glycine plays an aetiological role. We present a meta-analysis of genome-wide association studies for glycine in 80,003 participants and investigate the causality and potential mechanisms of the association between glycine and cardio-metabolic diseases using genetic approaches. We identify 27 genetic loci, of which 22 have not previously been reported for glycine. We show that glycine is genetically associated with lower CHD risk and find that this may be partly driven by blood pressure. Evidence for a genetic association of glycine with T2D is weaker, but we find a strong inverse genetic effect of hyperinsulinaemia on glycine. Our findings strengthen evidence for a protective effect of glycine on CHD and show that the glycine-T2D association may be driven by a glycine-lowering effect of insulin resistance.

Citing Articles

A cohort study reveals shared and distinct serum metabolic biomarkers for major adverse cardiovascular events in middle-aged and older adults.

Ren Y, Chen B, Zhang H, Xu S Geroscience. 2025; .

PMID: 39904969 DOI: 10.1007/s11357-025-01544-6.


Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models.

Biswas S, Hilser J, Woodward N, Wang Z, Gukasyan J, Nemet I Nutrients. 2025; 17(1.

PMID: 39796632 PMC: 11723402. DOI: 10.3390/nu17010198.


DENND5B Gene Expression as a Trigger for the Development of Diabetes Mellitus-Peripheral Artery Disease: Insights from a Univariate and Multivariate Mendelian Randomization Study.

Li Q, Cao F, Gao X, Xu Y, Li B, Hu T Glob Heart. 2024; 19(1):91.

PMID: 39649955 PMC: 11623097. DOI: 10.5334/gh.1373.


Metabolic Signatures of Blood Pressure and Risk of Cardiovascular Diseases.

Manou M, Papagiannopoulos C, Chalitsios C, Asimakopoulos A, Markozannes G, Bullo M J Am Heart Assoc. 2024; 13(23):e036573.

PMID: 39575750 PMC: 11681602. DOI: 10.1161/JAHA.124.036573.


Dietary amino acids intake and all-cause and cause-specific mortality: results from the Golestan Cohort Study.

Mansour A, Sajjadi-Jazi S, Mirahmad M, Asili P, Sharafkhah M, Masoudi S Nutr J. 2024; 23(1):141.

PMID: 39522023 PMC: 11549823. DOI: 10.1186/s12937-024-01044-x.


References
1.
Narisawa A, Komatsuzaki S, Kikuchi A, Niihori T, Aoki Y, Fujiwara K . Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum Mol Genet. 2011; 21(7):1496-503. PMC: 3298276. DOI: 10.1093/hmg/ddr585. View

2.
Day N, Oakes S, Luben R, Khaw K, Bingham S, Welch A . EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999; 80 Suppl 1:95-103. View

3.
Gall W, Beebe K, Lawton K, Adam K, Mitchell M, Nakhle P . alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One. 2010; 5(5):e10883. PMC: 2878333. DOI: 10.1371/journal.pone.0010883. View

4.
Nguyen D, Hsu J, Jahoor F, Sekhar R . Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J Clin Endocrinol Metab. 2013; 99(1):169-77. PMC: 3879663. DOI: 10.1210/jc.2013-2376. View

5.
Van den Eynden J, Ali S, Horwood N, Carmans S, Brone B, Hellings N . Glycine and glycine receptor signalling in non-neuronal cells. Front Mol Neurosci. 2009; 2:9. PMC: 2737430. DOI: 10.3389/neuro.02.009.2009. View